Axsome Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.
CEOHerriott Tabuteau
CEOHerriott Tabuteau
Employees683
Employees683
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2012
Founded2012
Employees683
Employees683
AXSM Key Statistics
Market cap5.10B
Market cap5.10B
Price-Earnings ratio-17.97
Price-Earnings ratio-17.97
Dividend yield—
Dividend yield—
Average volume706.38K
Average volume706.38K
High today$106.85
High today$106.85
Low today$103.02
Low today$103.02
Open price$106.00
Open price$106.00
Volume874.14K
Volume874.14K
52 Week high$139.13
52 Week high$139.13
52 Week low$64.11
52 Week low$64.11
AXSM News
TipRanks 2d
Axsome Therapeutics Secures $570M Loan with BlackstoneProtect Your Portfolio Against Market Uncertainty Axsome Therapeutics ( (AXSM) ) has issued an announcement. On May 8, 2025, Axsome Therapeutics entered into...
Analyst ratings
100%
of 18 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AXSM. This list is generated using Robinhood data, and it’s not a recommendation.